ACP Diabetes Monthly
Welcome to this month's issue of ACP Diabetes Monthly, an update for internists published by the American College of Physicians.
In the News for the month of October 2016
New drugs did not change overall glycemic control in U.S. patients with type 2 diabetes, study finds
The proportion of type 2 diabetes patients with HbA1c levels of 9% or greater or HbA1c between 8% and 9% increased from 2006 to 2013, while the proportion with an HbA1c less than 6% decreased. More...
3 biomarkers may refine standard cardiovascular risk algorithms for diabetes
Elevations in high-sensitivity troponin T or N-terminal pro-B-type natriuretic peptide were significantly associated with risk of cardiovascular death, myocardial infarction, and hospitalization for heart failure, while C-reactive protein was a less significant predictor. More...
Weekly GLP-1 analogue associated with reduced MI, stroke risk, industry study finds
The trial of semaglutide included 3,297 patients with type 2 diabetes, 83% of whom had established cardiovascular disease, chronic kidney disease, or both. More...
MKSAP quiz: Management of new type 1 diabetes
This month's quiz asks readers to manage recent hypoglycemia in a 21-year-old woman diagnosed 3 months ago with type 1 diabetes after presenting to the emergency department with diabetic ketoacidosis. More...
From ACP Journal Club
Intensive glucose-lowering in type 2 diabetes was linked to hypoglycemia in high-complexity patients
More than 20% of patients with type 2 diabetes received treatment more intensive than that recommended by HbA1c-based guidelines, a study of Medicare patients found. More...
From Annals of Internal Medicine
Beyond the Guidelines: Should we screen for type 2 diabetes?
Whether to screen a patient for type 2 diabetes is the focus of a Beyond the Guidelines feature in the Oct. 4 Annals of Internal Medicine. More...
From ACP Internist Weekly
Ischemic heart disease linked to worse prognosis in heart failure patients with type 2 diabetes
Mortality risk was highest in patients who had both type 2 diabetes and ischemic heart disease and had not had previous revascularization. More...
Spotlight on new technologies for type 1 diabetes
Two recent studies and FDA approval of the first "artificial pancreas" highlight new technological advances in type 1 diabetes care. More...
Physician editor: David V. O'Dell, MD, FACP
About ACP Diabetes Monthly
ACP Diabetes Monthly is a monthly newsletter produced by the staff of ACP Internist. It is automatically sent to all College members who have an e-mail address on file with ACP.
To sign up for ACP Diabetes Monthly, please click here.
Copyright © by American College of Physicians.
A 47-year-old man is evaluated during a routine examination. He has no symptoms. Medical history is significant for a bicuspid aortic valve. He is not taking any medications. Following a physical exam, cardiac exam, and echocardiogram, what is the most appropriate management?
Not an ACP Member?
Join today and discover the benefits waiting for you.
ACP offers different categories of membership depending on your career stage and professional status. View options, pricing and benefits.
A New Way to Ace the Boards!
Ensure you're board-exam ready with ACP's Board Prep Ace - a multifaceted, self-study program that prepares you to pass the ABIM Certification Exam in internal medicine. Learn more.